SL
Silexion Therapeutics Ltd.
SLXNW · NASDAQ
$0.01 -62.50% (-$0.02)
1M -40.00%
Market Cap $6.73K
P/E Ratio -
Div. Yield -
ROE 276.59%
Bulios Fair Price
$0.01
16.7% downside
Trenutna cena
$0.012
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica SLXNW trenutno podcenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Weak
2/9Valuation
100 /100
Cheap P/B 0.15x
P/E N/A
EV/EBITDA N/A
Growth
-
N/A EPS growth N/A
Rev. growth N/A
Book val. growth N/A
Profitability
-
N/A Gross margin N/A
Net margin N/A
FCF margin N/A
Quality
40 /100
Average ROIC 628.40%
ROE 276.59%
Asset turnover 0.00x
Debt
8 /100
High Debt/Equity 32.05x
Current ratio 0.94x
Int. coverage -2,346.83x
Stability
19 /100
Unstable Beta -0.27x
EPS volatility 7,313.59%
Profitable years 0
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o SLXNW
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Ilan Hadar
Employees
14
Headquarters
Jerusalem
Prihajajoči dogodki
18 NOV.
Earnings
Upcoming earnings report